Atlas Trials

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

Clinical trial NCT00743002 · COMPLETED

Trial details

NCT number
NCT00743002
Sponsor
OPKO Health, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2008-08-01
Primary completion
2009-12-01
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.